Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · Real-Time Price · USD

5.98

-0.25 (-4.01%)

At close: Sep 23, 2026, 4:00 PM EDT

6.00

+0.02 (0.28%)

After-hours: Sep 23, 2026, 7:30 PM EDT

Market Cap	2.96B -61.7%
Revenue (ttm)	n/a
Net Income	-7.05M
EPS	-0.01
Shares Out	495.47M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	134,342
Open	6.14
Previous Close	6.23
Day's Range	5.92 - 6.16
52-Week Range	4.51 - 69.00
Beta	1.43
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About RGC

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

IPO Date Jul 16, 2021

Employees 10

Stock Exchange NASDAQ

Ticker Symbol RGC

Website https://www.regencellbioscience.com

Full Company Profile

Financial Performance

Financial Statements

News

Regencell Bioscience rises 25.2%

Regencell Bioscience (RGC) is up 25.2%, or $1.50 to $7.45.

2 months ago - TheFly

Regencell Bioscience rises 29.6%

Regencell Bioscience (RGC) is up 29.6%, or $1.80 to $7.89.

2 months ago - TheFly

Regencell Bioscience falls -16.0%

Regencell Bioscience (RGC) is down -16.0%, or -$1.20 to $6.29.

2 months ago - TheFly

Regencell Bioscience falls -11.5%

Regencell Bioscience (RGC) is down -11.5%, or -86c to $6.63.

2 months ago - TheFly

Regencell Bioscience falls -13.6%

Regencell Bioscience (RGC) is down -13.6%, or -$1.16 to $7.40.

3 months ago - TheFly

Regencell Bioscience falls -14.3%

Regencell Bioscience (RGC) is down -14.3%, or -$1.58 to $9.50.

3 months ago - TheFly

Relevant Gold Announces Results of Annual and Special General Meeting and Welcomes New Board Member

VANCOUVER, BC / ACCESS Newswire / June 18, 2026 / Relevant Gold Corp. (TSXV:RGC)(OTCQB:RGCCF) (the "Company" or "Relevant Gold") is pleased to announce the voting results from its Annual and Special G...

3 months ago - Accesswire

Relevant Gold South Pass VTEM Survey Defines Multi-Kilometre Structural Corridors with High Priority Drill Targets

Airborne VTEM and magnetics survey identifies 44+ EM anomalies, including 15 high-priority targets, several coincident with known gold-bearing structures, surface geochemistry and 2024 drilling VANCOU...

3 months ago - Accesswire

Regencell Bioscience falls -14.7%

Regencell Bioscience (RGC) is down -14.7%, or -$2.46 to $14.27.

3 months ago - TheFly

RGC Investors Have Rights – If You Lost Money Investing in Regencell Bioscience Holdings Limited Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO, May 08, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings ...

4 months ago - GlobeNewsWire